Sherrie McCain Banned from Importing Drugs After Conviction
Published Date: 2/19/2026
Notice
Summary
Sherrie R. McCain is officially banned for 5 years from importing any drugs into the U.S. because she was convicted of bringing in a misbranded drug. She didn’t respond to the FDA’s notice or ask for a hearing, so the ban started on February 19, 2026. She can apply to end the ban anytime, but until then, no drug imports from her!
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
5-year drug-import ban for named individual
Sherrie R. McCain is banned for 5 years from importing or offering for import any drug into the United States, effective February 19, 2026. The debarment follows her October 24, 2024 felony conviction for introduction into interstate commerce of a misbranded drug, and she may apply at any time for termination of debarment under section 306(d)(1) (applications accepted via https://www.regulations.gov or by mail to Docket No. FDA-2025-N-0309).
Assisting or importing with her is prohibited
As of February 19, 2026, importing or offering for import any drug by, with the assistance of, or at the direction of Sherrie R. McCain is a prohibited act under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 331(cc)). Anyone who imports drugs in concert with or at the direction of Ms. McCain would be engaging in a prohibited act under the cited statute.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11762 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products
The FDA is asking for approval to keep collecting info from seafood processors and importers to make sure fish products are safe using a system called HACCP. This affects anyone who processes or imports fish and requires them to keep records showing they’re following safety rules. Comments on this plan are open until July 13, 2026, and there’s no new cost, just a continuation of current paperwork.
2026-11740 — Medical Devices; Immunology and Microbiology Devices; Classification of the Spinal Muscular Atrophy Newborn Screening Test System
The FDA is officially putting the Spinal Muscular Atrophy (SMA) newborn screening test into class II, meaning it has special safety rules but fewer hurdles than the strictest category. This change helps make the test safer and easier to get to babies who need it, starting June 11, 2026, with the classification effective since November 2022. Labs and device makers will benefit from clearer rules and faster access, helping catch SMA early without extra costs or delays.
2026-11739 — Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS-CoV-2 Viral Targets From Clinical Specimens in Near-Patient Settings
The FDA is officially putting simple COVID-19 rapid test devices into a safer, easier-to-manage category called Class II. This change means these tests can get to patients faster and with fewer hoops to jump through, while still making sure they work well and stay safe. Starting June 11, 2026, companies making these tests will follow new rules that help speed up innovation without extra costs.
2026-11760 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishment, Maintenance, and Availability of Records; Additional Traceability Records for Certain Foods
The FDA is asking for approval to collect extra records from food businesses that handle certain high-risk foods. This helps track food sources quickly to keep everyone safe. Food companies should get ready to keep and share these new records, and comments on this plan are due by July 13, 2026.
2026-11578 — Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information
The FDA just gave a thumbs-up to adding bemotrizinol as a new active ingredient in sunscreens, letting it be used up to 6% concentration. This means sunscreen makers can now include this ingredient, which is safe and effective, in their products. The change is official as of June 10, 2026, and could lead to better sun protection options without extra costs for consumers.
2026-11589 — Medical Devices; Ear, Nose, and Throat Devices; Classification of the Combined Acoustic and Electrical External Stimulation Device for the Relief of Tinnitus
The FDA has officially placed the combined acoustic and electrical external stimulation device for tinnitus relief into class II, meaning it now has special safety rules but fewer regulatory hurdles. This change helps patients get access to this innovative device faster and ensures it’s safe and effective. The new classification is effective June 10, 2026, with the rules applying retroactively from March 6, 2023.
Previous / Next Documents
Previous: 2026-03250 — Revocation of Authorization of Emergency Use of ExThera Medical Corporation Seraph 100 Microbind Affinity Blood Filter (Seraph 100); Availability
The FDA has officially ended the emergency use approval for ExThera Medical’s Seraph 100 blood filter as of November 24, 2025. This means hospitals and patients can no longer use this device under emergency rules. The change was requested by the company, so no surprise bills or sudden costs are expected.
Next: 2026-03253 — Justin Insprucker: Final Debarment Order
Justin Insprucker is officially banned for 5 years from importing any drugs into the U.S. because he was convicted of a serious crime involving fake drugs. He didn’t respond to the FDA’s notice, so the ban started on February 19, 2026. He can apply to end the ban anytime, but must follow special rules to keep his info private.